Search

Your search keyword '"Curran, Kevin"' showing total 1,868 results

Search Constraints

Start Over You searched for: Author "Curran, Kevin" Remove constraint Author: "Curran, Kevin"
1,868 results on '"Curran, Kevin"'

Search Results

151. Impact of Rabbit Anti-Thymocyte Globulin (rATG) Exposure in Ex Vivo T-Cell Depleted Hematopoietic Cell Transplantation in Children and Young Adults

152. Clinical Outcomes and Salvage Therapies of Pediatric Patients with Progressive B-ALL Following CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy

153. Donor Derived Leukemia in a Recipient of Allogeneic Hematopoietic Cell Transplantation for Recessive Dystrophic Epidermolysis Bullosa

154. High Disease Burden and Severe Neutropenia Predict HLH Toxicity in Patients with B-Acute Lymphoblastic Leukemia (B-ALL) Treated with Tisagenlecleucel in the PRWCC

155. Busulfan Exposure Is Associated with Survival in Pediatric and Adult AML/MDS Patients Undergoing a CD34+ Selected Allogeneic Hematopoietic Cell Transplantation

156. Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell Transplantation

160. After the QSP: Post-Acquisition Pitfalls When Making a Code Sec. 338(g) Election.

162. MANET Location Prediction Using Machine Learning Algorithms

166. Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials

168. Obesity Associates with Inferior Outcomes and Toxicity in Pediatric and Young Adult Patient with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Treated with Commercially Manufactured Tisagenlecleucel

169. Standard Cytogenetic Risk Stratification Is Not Predictive of CD19 CAR Outcomes and Impact of Disease Burden Varies between Cytogenetic Risk Groups

170. Antigen Directed Therapy Pre-Transplant Confers Superior Post-Transplant Survival Outcome Compared to Conventional Chemotherapy in Pediatric Patients with Relapsed and Refractory B-ALL

171. Peripheral Blast Count at Apheresis Acts Independent of Disease Burden As a Risk Factor for Survival Following Tisagenlecleucel in Children and Young Adults

176. Autonomous Querying for Knowledge Networks

177. Knowledge-Based Reasoning Through Stigmergic Linking

178. Knowledge Networks

180. Design of a Tourist Driven Bandwidth Determined MultiModal Mobile Presentation System

181. Introducing IP Domain Flexible Middleware Stacks for Multicast Multimedia Distribution in Heterogeneous Environments

184. ALL-173 Evolution of Tisagenlecleucel Use for the Treatment of Pediatric and Young Adult Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL): Center for International Blood & Marrow Transplant Research (CIBMTR) Registry Results

185. Evolution of Tisagenlecleucel Use for the Treatment of Pediatric and Young Adult Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL): Center for International Blood & Marrow Transplant Research (CIBMTR) Registry Results

187. Investigating the Human Computer Interaction Problems with Automated Teller Machine Navigation Menus

188. A Multilingual Mobile University Information Portal Designed to Cater for Visiting Overseas Students

189. An Investigation into Web Content Accessibility Guideline Conformance for an Aging Population

191. Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy.

192. Cross-Border Targeted Radio in Vancouver-Bellingham: Differing Treatments of South Asian and Christian Broadcasters.

197. Outcomes of Hispanic and non-Hispanic white pediatric and young adult patients with B-cell acute lymphoblastic leukemia after commercial tisagenlecleucel.

Catalog

Books, media, physical & digital resources